眼科

• 论著 • 上一篇    下一篇

45例Stevens-Johnson综合征眼部并发症的临床分析

何彦  张爱雪  王智群  张阳  孙旭光   

  1. 410010 长沙,中南大学湘雅二医院眼科,中南大学湘雅二医院眼科研究所(何彦);100005首都医科大学附属北京同仁医院 北京同仁眼科中心 眼科学与视觉科学北京市重点实验室 北京市眼科研究所(张爱雪、王智群、张阳、孙旭光)
     
  • 收稿日期:2015-03-16 出版日期:2016-11-25 发布日期:2016-11-29
  • 通讯作者: 孙旭光,Email:sunxg1955@163.com

Ocular manifestations of 45 cases with Stevens-Johnson syndrome

HE Yan1, ZHANG Ai-xue2, WANG Zhi-qun2, ZHANG Yang2, SUN Xu-guang2   

  1. 1. Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Eye Institute of The Second Xiangya Hospital of Central South University, Changsha 410010, China; 2. Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing  Key Laboratory of Ophthalmology and Visual Science, Beijing Institute of Ophthalmology, Beijing 100005, China
  • Received:2015-03-16 Online:2016-11-25 Published:2016-11-29
  • Contact: SUN Xu-guang, Email: sunxg1955@163.com

摘要:

目的 分析Stevens-Johnson综合征(Stevens-Johnson syndrome, SJS)患者眼部并发症的临床特征。设计 回顾性病例系列。研究对象 2010年8月至2014年6月北京同仁医院眼科门诊因SJS 综合征出现眼部并发症的45例患者。方法 回顾分析患者病历资料,并对数据进行统计学分析。主要指标 患者一般情况、病史及病程,症状、体征及相关性疾病以及临床处理。结果 45例患者(90眼),男性21例(46.7%),平均年龄(28.0±20.2)岁,均双眼发病。自SJS发病到眼科就诊的平均时间为(43.2±75.9)个月。眼表损害程度轻度者15眼(16.6%),平均视力LogMAR 0.55±0.91;中度者25眼(27.8%),平均视力LogMAR 0.52±0.82;重度者50眼(55.6%),平均视力LogMAR 1.33±1.05。眼部重度受累患者视力与轻、中度患者差异显著(P=0.038)。SJS发病年龄及病程时长与眼表严重程度分级相关性无统计学意义(P=0.47,0.143)。68眼(75.6%)并发干眼,63眼(66.7%)并发角膜病变,70眼(77.8%)并发眼睑结构改变及睑板腺功能障碍。结论 SJS可引起严重眼部并发症,发病后眼部浸润严重程度与发病年龄、性别、发病时长均无相关,及时合理地针对角结膜干燥、眼睑结构异常以及角膜病变的对症治疗可提高患者生存质量。(眼科, 2016, 25: 382-386)

关键词: Stevens-Johnson 综合征/诊断, Stevens-Johnson 综合征/治疗

Abstract:

Objective To report the clinical ocular features of patients with Stevens- Johnson syndrome (SJS). Design Retrospective case series. Participants 90 eyes in 45 patients with a history of SJS and ocular involvement between August 2010 and June 2014 at Beijing Tongren Eye Center. Methods The clinical charactristics of 45 patients with a history of SJS were reviewed, and the data were analyzed with statistical software. Main Outcome Measures  The information collected for analysis included the ophthalmological history, visual acuity, adjunct treatments, and complications. Results A total of 45 patients (90 eyes) were recorded, 21 males (46.7%), with the average age of 28.0±20.2 years old. Average onset-treatment interval wsa 43.2±75.9 months. In the 90 affected eyes, 15 eyes (16.6%) were mild affected with an average BCVA LogMAR 0.55±0.91, 25 eyes (27.8%) were moderately affected with an average BCVA LogMAR 0.52±0.82, and 50 eyes (55.6%) were severely with an average BCVA LogMAR 1.33±1.05. Difference in BCVA between severe and other two groups were significant (P=0.038), and the differences of affected age and affected interval between severity groups had no statistical significance (P=0.47, 0.143 respectively). Sixty-eight eyes(75.6%) were complicated with dry eye disease, 63 eyes(66.7%) had cornea involvement, and 70 eyes (77.8%) experienced dysfunction of eyelids and meibomian glands. Conclusions SJS is potential vision threatening general disease. Severity of ocular surface lesion does not associated with age, gender, and duration. With careful patient care for secondary dry eye disease, eyelid abnormality and corneal neovascularization, reasonable life quality may frequently be achieved. (Ophthalmol CHN, 2016, 25: 382-386)

Key words: Stevens-Johnson syndrome/diagnosis, Stevens-Johnson syndrome/therapy